| Literature DB >> 22211093 |
Cenk Erdal1, Gökhan Karakülah, Emel Fermancı, Imge Kunter, Erdem Silistreli, Tülay Canda, Esra Erdal, Hasan Hepaguslar.
Abstract
BACKGROUND: Acute myocardial infarction (AMI) remains as one of the most common lethal diseases in the world and therefore it is necessary to understand its effect on molecular basis. Genome-wide microarray analysis provides us to predict potential biomarkers and signaling pathways for this purpose.Entities:
Keywords: Acute myocardial infarction; molecular response
Mesh:
Substances:
Year: 2011 PMID: 22211093 PMCID: PMC3245415 DOI: 10.7150/ijms.9.74
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Fig 1Histopathology of the infarct zone obtained after LADC ligation. The upper panels are representative sections of infarct obtained from an animal 30th min after LADC ligation stained with hematoxylin and eosin (A) or trichrome (B). The gross external appearance of this region was unremarkable except for regional discoloration. Histological analysis revealed that tissue integrity was abnormal including regional vacuolation and disruption of myofibrils organization with interstitial hemorrhagic foci and intermittent cellular infiltrates.
GO enrichment analysis MI ischemic and remote zones in response to LCAL.
| Gene Ontology term | SHAM/ischemic vs. MI/ischemic zone | SHAM/remote vs. MI/remote zone | ||
|---|---|---|---|---|
| p-value | # of Genes | p-value | # of Genes | |
| - Response to chemical stimulus (GO:0042221) | 3.78e-05 | 17 | 0.0021 | 27 |
| 0.0030 | 4 | 0.0041 | 6 | |
| 5.26e-05 | 5 | 0.0038 | 5 | |
| 4.53e-05 | 4 | 0.0016 | 4 | |
| 3.37e-05 | 4 | 0.0012 | 4 | |
| 1.00e-04 | 3 | N/A | not significant | |
| 0.0002 | 4 | N/A | not significant | |
| - Immune response (GO:0006955) | 0.0004 | 8 | N/A | not significant |
| 0.0008 | 6 | N/A | not significant | |
| 1.71e-07 | 5 | N/A | not significant | |
| 5.55e-05 | 5 | N/A | not significant | |
| - Catecholamine metabolic process (GO:0006584) | 0.0128 | 2 | N/A | not significant |
| - Binding (GO:0005488) | 0.0007 | 41 | 0.0085 | 104 |
| 0.0123 | 32 | 0.0120 | 80 | |
| 1.00e-04 | 5 | N/A | not significant | |
| 2.02e-07 | 5 | 0.0005 | 4 | |
| 0.0463 | 5 | 0.0083 | 12 | |
| 0.0277 | 2 | N/A | not significant | |
| - Intracellular (GO:0005622) | 0.0377 | 35 | 0.0006 | 94 |
| - Actin cytoskeleton (GO:0015629) | 0.0055 | 4 | N/A | not significant |
| 0.0004 | 3 | N/A | not significant | |
| not significant | N/A | 0.0012 | 6 | |
| not significant | N/A | 0.0052 | 4 | |
| not significant | N/A | 0.0006 | 4 | |
| - Regulation of anti-apoptosis (GO:0045767) | not significant | N/A | 0.0010 | 4 |
| - Caveola assembly (GO:0070836) | not significant | N/A | 1.00e-04 | 2 |
| - Regulation of cytoskeleton organization (GO:0051493) | not significant | N/A | 0.0002 | 7 |
| not significant | N/A | 0.0011 | 4 | |
| not significant | N/A | 0.0033 | 4 | |
| - Regulation of endothelial cell proliferation (GO:0001936) | not significant | N/A | 0.0036 | 3 |
| not significant | N/A | 0.0090 | 9 | |
| not significant | N/A | 0.0079 | 3 | |
| not significant | N/A | 0.0007 | 4 | |
| not significant | N/A | 0.0113 | 22 | |
| not significant | N/A | 0.0195 | 12 | |
| not significant | N/A | 0.0425 | 6 | |
| not significant | N/A | 0.0006 | 24 | |
| not significant | N/A | 0.0079 | 9 | |
| - Envelope (GO:0031975) | not significant | N/A | 0.0197 | 11 |
| not significant | N/A | 0.0219 | 11 | |
| not significant | N/A | 0.0389 | 8 | |
KEGG pathways in response to LCAL in MI ischemic and remote zones.
| KEGG Pathway name | Corresponding genes | p-value |
|---|---|---|
| NOD-like receptor signaling pathway | Cxcl2, Cxcl1, Ccl2, Ccl7 | 1.65e-05 |
| Chemokine signaling pathway | Cxcl2, Cxcl1, Ccl2, Ccl7, Cxcl10 | 0.0002 |
| Focal adhesion | Col1a1, Pdpk1, Mylpf, Arhgap5 | 0.0033 |
| Leukocyte transendothelial migration | Mylpf, Arhgap5, Cybb | 0.0063 |
| Cytokine-cytokine receptor interaction | Cxcl2, Ccl2, Cxcl10 | 0.0172 |
| Toll-like receptor signaling pathway | Fos, Cxcl10 | 0.0260 |
| Adherens junction | Actb, Ctnnb1, Csnk2a1 | 0.0315 |
| Tight junction | Prkci, Actb, Ctnnb1, Myl7, Ppp2r1a, Csnk2a1 | 0.0014 |
| Focal adhesion | Col1a1, Actb, Pdpk1, Cav1, Ctnnb1, Myl7, Cav2 | 0.0022 |
| Regulation of actin cytoskeleton | Arpc2, Cfl1, Pfn1, Actb, Myl7 | 0.0432 |
| Viral myocarditis | Actb, Cav1, Eif4g2, RT1-Ba | 0.0027 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | Cacna2d1, Dsc2, Actb, Ctnnb1 | 0.0039 |
| NOD-like receptor signaling pathway | Cxcl1, Hsp90ab1, Ccl2 | 0.0103 |
| PPAR signaling pathway | Fabp4, Pdpk1, Dbi | 0.0315 |
| Ubiquitin mediated proteolysis | Ube2g1, Ube2s, Map3k1, Nedd4 | 0.0309 |
| Spliceosome | Nhp2l1, Snrpf, Lsm7, Smndc1 | 0.0258 |
| Ribosome | Rps10, Rps24, Rpl34 | 0.0354 |
Fig 2SHAM/remote zone and MI/remote zone comparison of altered genes in Gene Ontology terms.